Summary

Report Scope
The current report analyzes market trends in cancer profiling and pathway technologies, providing 2024 data, 2025 estimates, compound annual growth rate (CAGR) projections through 2030 (forecast period: 2025–2030), and regional markets for cancer profiling and pathway technologies. Highlights include the current and future market potential of cancer profiling and pathway technologies, as well as an analysis of the competitive environment, encompassing regulatory scenarios, drivers, restraints, and opportunities. The report also covers market shares of industry leaders.
The report provides detailed information and quantitative analysis on cancer profiling and pathway technologies used in oncology research and clinical practice. The focus is on technological platforms, tools, and services that enable the molecular profiling of tumors (both tissue-based and liquid biopsy-based) and the interpretation of results at the pathway and network levels.
The global cancer profiling and pathway technologies market is segmented by product type, profiling type, technology type, application, and geographic region.
The market is segmented into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. Within each region, there is an analysis of major countries, including the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for the base year 2024 with forecasts for 2025 through 2030.
The report addresses the following aspects of the market:
- Types of cancer profiling and pathway technologies.
- Global market size and segmentation.
- Constraints and drivers.
- Forecasts through 2030.
- Market shares, competitiveness, and industry structure.
- Potential long-term impacts on the global cancer profiling and pathway technologies market.
Report Includes
- 146 data tables and 48 additional tables
- An analysis of the global market for cancer profiling and pathways technologies
- Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
- Estimates of the current market size and revenue prospects for the global market, accompanied by a market share analysis by product type, profiling type, technology, application and region
- Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impact of macroeconomic variables
- Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
- Patent review, featuring key granted and published patents
- Analysis of the industry structure, including companies’ market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the current status and ESG risk ratings of leading companies
- Profiles of the leading global companies, including Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., and Exact Sciences Corp.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Porter’s Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Macroeconomic Factor Analysis
Healthcare Expenditure
Demographic Shifts and Disease Burden
Impact of U.S. Tariffs (Trade Policy and Supply Chain Risk)
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rising Global Cancer Incidence Across Major Tumor Types
Shift Toward Precision Oncology and Biomarker-Driven Care
Expansion of Companion Diagnostics and Reimbursement for Molecular Tests
Advances in Liquid Biopsy, Single-Cell, and Multi-Omics Platforms
Market Restraints
High Test Costs and Affordability Constraints
Data Integration, Standardization, and Interoperability Challenges
Shortage of Skilled Molecular and Bioinformatics Expertise
Market Opportunities
Development of Comprehensive Genomic and Multi-Omics Panels
Expansion of MRD, Early Detection, and Screening Applications
Chapter 4 Regulatory Landscape
Overview
North America
U.S. (FDA, CMS/CLIA)
Europe
Asia-Pacific
Japan (PMDA/MHLW)
India (CDSCO, ICMR, and National Guidelines)
Other Asia-Pacific Regulators
Rest of the World
Latin America – Brazil (ANVISA)
Middle East and Africa
Chapter 5 Emerging Technologiesand Developments
Overview
Ultra-High-Throughput and Long-Read Sequencing
Single-Cell and Spatial Profiling Technologies
High-Plex Proteomics and Multiplex IHC/Imaging Platforms
Pipeline and Clinical Analysis
Key Takeaways
Pipeline Analysis
Clinical Trials Analysis
Clinical Trial Studies on Cancer Profiling and Pathway Technologies
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Cancer Profiling and Pathway Technologies Market, by Product Type
Key Takeaways
Reagents, Kits, and Consumables
Instruments and Systems
Software and Bioinformatics
Global Cancer Profiling and Pathway Technologies Market, by Profiling Type
Key Takeaways
Genomic Profiling
Transcriptomic Profiling
Proteomic Profiling
Epigenomic Profiling
Multi-Omics/Integrative Profiling
Others
Global Cancer Profiling and Pathway Technologies Market, by Technology Type
Key Takeaways
Next-Generation Sequencing (NGS)
PCR-Based Platforms
IHC/ISH Platforms
Flow Cytometry and Related Cytometric Platforms
Liquid Biopsy Platforms
Others
Global Cancer Profiling and Pathway Technologies Market, by Application
Key Takeaways
Research and Biomarker Discovery
Treatment Selection and Monitoring
Diagnostics and Screening
Prognostics and Risk Stratification
Other Applications
Geographic Breakdown
Global Cancer Profiling and Pathway Technologies Market, by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
The Middle East and Africa
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Strategic Analysis
Chapter 8 Sustainability in Cancer Profiling and Pathway Technologies Market: An ESG Perspective
Overview
ESG in the Cancer Profiling and Pathway Technologies Market
Environmental Impact
Social Impact
Governance Impact
ESG Risk Ratings
Conclusion
Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
10X GENOMICS INC.
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
CARIS LIFE SCIENCES
EXACT SCIENCES CORP.
F. HOFFMANN-LA ROCHE LTD.
FOUNDATION MEDICINE INC.
GRAIL INC.
GUARDANT HEALTH INC.
ILLUMINA INC.
NANOSTRING (BRUKER SPATIAL BIOLOGY)
NEOGENOMICS INC.
QIAGEN
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.
Some Emerging Companies in the Cancer Profiling and Pathway Technologies Market

ページTOPに戻る

List of Tables/Graphs

List of Tables
Summary Table : Global Market for Cancer Profiling and Pathway Technologies, by Region, Through 2030
Table 1 : List of Selected Clinical Trials Studies on Cancer Profiling and Pathway Technologies, 2020–2025
Table 2 : Global Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 3 : Global Market for Reagents, Kits, and Consumables in Cancer Profiling and Pathway Technologies, by Region, Through 2030
Table 4 : Global Market for Instruments and Systems in Cancer Profiling and Pathway Technologies, by Region, Through 2030
Table 5 : Global Market for Software and Bioinformatics in Cancer Profiling and Pathway Technologies, by Region, Through 2030
Table 6 : Global Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 7 : Global Market for Cancer Profiling and Pathway Technologies in Genomic Profiling, by Region, Through 2030
Table 8 : Global Market for Cancer Profiling and Pathway Technologies in Transcriptomic Profiling, by Region, Through 2030
Table 9 : Global Market for Cancer Profiling and Pathway Technologies in Proteomic Profiling, by Region, Through 2030
Table 10 : Global Market for Cancer Profiling and Pathway Technologies in Epigenomic Profiling, by Region, Through 2030
Table 11 : Global Market for Cancer Profiling and Pathway Technologies in Multi-Omics / Integrative Profiling, by Region, Through 2030
Table 12 : Global Market for Cancer Profiling and Pathway Technologies in Othersby Region, Through 2030
Table 13 : Global Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 14 : Global Market for Cancer Profiling and Pathway Technologies in Next-Generation Sequencing (NGS), by Region, Through 2030
Table 15 : Global Market for Cancer Profiling and Pathway Technologies in PCR-based Platforms, by Region, Through 2030
Table 16 : Global Market for Cancer Profiling and Pathway Technologies in IHC/ISH Platforms, by Region, Through 2030
Table 17 : Global Market for Cancer Profiling and Pathway Technologies in Flow Cytometry and Related Cytometric Platforms, by Region, Through 2030
Table 18 : Global Market for Cancer Profiling and Pathway Technologies in Liquid Biopsy Platforms, by Region, Through 2030
Table 19 : Global Market for Cancer Profiling and Pathway Technologies in Other Technology, by Region, Through 2030
Table 20 : Global Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 21 : Global Market for Cancer Profiling and Pathway Technologies in Research and Biomarker Discovery, by Region, Through 2030
Table 22 : Global Market for Cancer Profiling and Pathway Technologies in Treatment Selection and Monitoring, by Region, Through 2030
Table 23 : Global Market for Cancer Profiling and Pathway Technologies in Diagnostics and Screening, by Region, Through 2030
Table 24 : Global Market for Cancer Profiling and Pathway Technologies in Prognostics and Risk Stratification, by Region, Through 2030
Table 25 : Global Market for Cancer Profiling and Pathway Technologies in Other Applications, by Region, Through 2030
Table 26 : Global Market for Cancer Profiling and Pathway Technologies, by Region, Through 2030
Table 27 : North American Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 28 : North American Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 29 : North American Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 30 : North American Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 31 : North American Market for Cancer Profiling and Pathway Technologies, by Country, Through 2030
Table 32 : U.S. Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 33 : U.S. Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 34 : U.S. Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 35 : U.S. Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 36 : Canadian Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 37 : Canadian Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 38 : Canadian Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 39 : Canadian Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 40 : Mexican Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 41 : Mexican Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 42 : Mexican Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 43 : Mexican Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 44 : European Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 45 : European Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 46 : European Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 47 : European Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 48 : European Market for Cancer Profiling and Pathway Technologies, by Country, Through 2030
Table 49 : German Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 50 : German Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 51 : German Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 52 : German Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 53 : U.K. Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 54 : U.K. Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 55 : U.K. Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 56 : U.K. Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 57 : French Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 58 : French Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 59 : French Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 60 : French Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 61 : Italian Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 62 : Italian Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 63 : Italian Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 64 : Italian Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 65 : Spanish Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 66 : Spanish Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 67 : Spanish Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 68 : Spanish Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 69 : Rest of Europe Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 70 : Rest of Europe Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 71 : Rest of Europe Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 72 : Rest of Europe Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 73 : Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 74 : Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 75 : Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 76 : Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 77 : Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Country, Through 2030
Table 78 : Chinese Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 79 : Chinese Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 80 : Chinese Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 81 : Chinese Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 82 : Japanese Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 83 : Japanese Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 84 : Japanese Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 85 : Japanese Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 86 : Indian Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 87 : Indian Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 88 : Indian Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 89 : Indian Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 90 : South Korean Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 91 : South Korean Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 92 : South Korean Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 93 : South Korean Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 94 : Australian Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 95 : Australian Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 96 : Australian Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 97 : Australian Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 98 : Rest of Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 99 : Rest of Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 100 : Rest of Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 101 : Rest of Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 102 : South American Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 103 : South American Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 104 : South American Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 105 : South American Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 106 : South American Market for Cancer Profiling and Pathway Technologies, by Country, Through 2030
Table 107 : Brazilian Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 108 : Brazilian Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 109 : Brazilian Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 110 : Brazilian Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 111 : Argentine Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 112 : Argentine Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 113 : Argentine Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 114 : Argentine Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 115 : Rest of South America Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 116 : Rest of South America Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 117 : Rest of South America Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 118 : Rest of South America Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 119 : MEA Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 120 : MEA Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 121 : MEA Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 122 : MEA Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 123 : MEA Market for Cancer Profiling and Pathway Technologies, by Sub-region, Through 2030
Table 124 : Middle East Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 125 : Middle East Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 126 : Middle East Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 127 : Middle East Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 128 : African Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 129 : African Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 130 : African Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 131 : African Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 132 : Strategic Initiatives in the Global Cancer Profiling and Pathway Technologies Market, 2024–2025
Table 133 : ESG Rankings for Leading Companies in the Cancer Profiling and Pathway Technologies Market, 2025*
Table 134 : Information Sources for this Report
Table 135 : Abbreviations Used in the Cancer Profiling and Pathway Technologies Market Report
Table 136 : 10X Genomics Inc.: Company Snapshot
Table 137 : 10X Genomics Inc.: Financial Performance, FY 2023 and 2024
Table 138 : 10X Genomics Inc.: Product Portfolio
Table 139 : 10X Genomics Inc.: News/Key Developments, 2022–2025
Table 140 : Agilent Technologies Inc.: Company Snapshot
Table 141 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
Table 142 : Agilent Technologies Inc.: Product Portfolio
Table 143 : Agilent Technologies Inc.: News/Key Developments, 2023–2025
Table 144 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 145 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 146 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 147 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024–2025
Table 148 : Caris Life Sciences: Company Snapshot
Table 149 : Caris Life Sciences: Product Portfolio
Table 150 : Caris Life Sciences: News/Key Developments, 2022–2024
Table 151 : Exact Sciences Corp.: Company Snapshot
Table 152 : Exact Sciences Corp.: Financial Performance, FY 2023 and 2024
Table 153 : Exact Sciences Corp.: Product Portfolio
Table 154 : Exact Sciences Corp.: News/Key Developments, 2022–2025
Table 155 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 156 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 157 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 158 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024–2025
Table 159 : Foundation Medicine Inc.: Company Snapshot
Table 160 : Foundation Medicine Inc.: Product Portfolio
Table 161 : Foundation Medicine Inc.: News/Key Developments, 2022–2025
Table 162 : Grail Inc.: Company Snapshot
Table 163 : Grail Inc.: Financial Performance, FY 2023 and 2024
Table 164 : Grail Inc.: Product Portfolio
Table 165 : Grail Inc.: News/Key Developments, 2024–2025
Table 166 : Guardant Health Inc.: Company Snapshot
Table 167 : Guardant Health Inc.: Financial Performance, FY 2023 and 2024
Table 168 : Guardant Health Inc.: Product Portfolio
Table 169 : Guardant Health Inc.: News/Key Developments, 2022–2025
Table 170 : Illumina Inc.: Company Snapshot
Table 171 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 172 : Illumina Inc.: Product Portfolio
Table 173 : Illumina Inc.: News/Key Developments, 2023–2025
Table 174 : Nanostring (Bruker Spatial Biology): Company Snapshot
Table 175 : Nanostring (Bruker Spatial Biology): Product Portfolio
Table 176 : Nanostring (Bruker Spatial Biology): News/Key Developments, 2024
Table 177 : Neogenomics Inc.: Company Snapshot
Table 178 : Neogenomics Inc.: Financial Performance, FY 2023 and 2024
Table 179 : Neogenomics Inc.: Product Portfolio
Table 180 : Neogenomics Inc.: News/Key Developments, 2025
Table 181 : Qiagen: Company Snapshot
Table 182 : Qiagen: Financial Performance, FY 2023 and 2024
Table 183 : Qiagen: Product Portfolio
Table 184 : Qiagen: News/Key Developments, 2022–2025
Table 185 : Sysmex Corp.: Company Snapshot
Table 186 : Sysmex Corp.: Financial Performance, FY 2023 and 2024
Table 187 : Sysmex Corp.: Product Portfolio
Table 188 : Sysmex Corp.: News/Key Developments, 2024–2025
Table 189 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 190 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 191 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 192 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022–2025
Table 193 : Few Emerging Companies in the Cancer Profiling and Pathway Technologies MarketList of Figures
Summary Figure : Global Market Shares for Cancer Profiling and Pathway Technologies, by Region, 2024
Figure 1 : Porter’s Five Forces Analysis of the Cancer Profiling and Pathway Technologies Market
Figure 2 : Global Health Expenditures, 2018-2024
Figure 3 : U.S. Health Expenditure Trend, 2019-2023
Figure 4 : Global Cancer Burden and Projections, 2022-2050
Figure 5 : Market Dynamics of Cancer Profiling and Pathway Technologies
Figure 6 : Global Cancer Burden and Projections, 2022-2050
Figure 7 : Estimated New Cancer Cases and Deaths in the U.S., 2024
Figure 8 : Global Market Shares for Cancer Profiling and Pathway Technologies, by Product Type, 2024
Figure 9 : Global Market Shares for Reagents, Kits, and Consumables in Cancer Profiling and Pathway Technologies, by Region, 2024
Figure 10 : Global Market Shares for Instruments and Systems in Cancer Profiling and Pathway Technologies, by Region, 2024
Figure 11 : Global Market Shares for Software and Bioinformatics in Cancer Profiling and Pathway Technologies, by Region, 2024
Figure 12 : Global Market Shares for Cancer Profiling and Pathway Technologies, by Profiling Type, 2024
Figure 13 : Global Market Shares for Cancer Profiling and Pathway Technologies in Genomic Profiling, by Region, 2024
Figure 14 : Global Market Shares for Cancer Profiling and Pathway Technologies in Transcriptomic Profiling, by Region, 2024
Figure 15 : Global Market Shares for Cancer Profiling and Pathway Technologies in Proteomic Profiling, by Region, 2024
Figure 16 : Global Market Shares for Cancer Profiling and Pathway Technologies in Epigenomic Profiling, by Region, 2024
Figure 17 : Global Market Shares for Cancer Profiling and Pathway Technologies in Multi-omics/Integrative Profiling, by Region, 2024
Figure 18 : Global Market Shares for Cancer Profiling and Pathway Technologies in Others, by Region, 2024
Figure 19 : Global Market Shares for Cancer Profiling and Pathway Technologies, by Technology Type, 2024
Figure 20 : Global Market Shares for Cancer Profiling and Pathway Technologies in Next-generation Sequencing (NGS), by Region, 2024
Figure 21 : Global Market Shares for Cancer Profiling and Pathway Technologies in PCR-Based Platforms, by Region, 2024
Figure 22 : Global Market Shares for Cancer Profiling and Pathway Technologies in IHC/ISH Platforms, by Region, 2024
Figure 23 : Global Market Shares for Cancer Profiling and Pathway Technologies in Flow Cytometry and Related Cytometric Platforms, by Region, 2024
Figure 24 : Global Market Shares for Cancer Profiling and Pathway Technologies in Liquid Biopsy Platforms, by Region, 2024
Figure 25 : Global Market Shares for Cancer Profiling and Pathway Technologies in Other Technology, by Region, 2024
Figure 26 : Global Market Shares for Cancer Profiling and Pathway Technologies, by Application, 2024
Figure 27 : Global Market Shares for Cancer Profiling and Pathway Technologies in Research and Biomarker Discovery, by Region, 2024
Figure 28 : Global Market Shares for Cancer Profiling and Pathway Technologies in Treatment Selection and Monitoring, by Region, 2024
Figure 29 : Global Market Shares for Cancer Profiling and Pathway Technologies in Diagnostics and Screening, by Region, 2024
Figure 30 : Global Market Shares for Cancer Profiling and Pathway Technologies in Prognostics and Risk Stratification, by Region, 2024
Figure 31 : Global Market Shares for Cancer Profiling and Pathway Technologies in Other Applications, by Region, 2024
Figure 32 : Global Market Shares for Cancer Profiling and Pathway Technologies, by Region, 2024
Figure 33 : North American Market Shares for Cancer Profiling and Pathway Technologies, by Product Type, 2024
Figure 34 : North American Market Shares for Cancer Profiling and Pathway Technologies, by Profiling Type, 2024
Figure 35 : North American Market Shares for Cancer Profiling and Pathway Technologies, by Technology Type, 2024
Figure 36 : North American Market Shares for Cancer Profiling and Pathway Technologies, by Application, 2024
Figure 37 : North American Market Shares for Cancer Profiling and Pathway Technologies, by Country, 2024
Figure 38 : European Market Shares for Cancer Profiling and Pathway Technologies, by Product Type, 2024
Figure 39 : European Market Shares for Cancer Profiling and Pathway Technologies, by Profiling Type, 2024
Figure 40 : European Market Shares for Cancer Profiling and Pathway Technologies, by Technology Type, 2024
Figure 41 : European Market Shares for Cancer Profiling and Pathway Technologies, by Application, 2024
Figure 42 : European Market Shares for Cancer Profiling and Pathway Technologies, by Country, 2024
Figure 43 : Asia-Pacific Market Shares for Cancer Profiling and Pathway Technologies, by Product Type, 2024
Figure 44 : Asia-Pacific Market Shares for Cancer Profiling and Pathway Technologies, by Profiling Type, 2024
Figure 45 : Asia-Pacific Market Shares for Cancer Profiling and Pathway Technologies, by Technology Type, 2024
Figure 46 : Asia-Pacific Market Shares for Cancer Profiling and Pathway Technologies, by Application, 2024
Figure 47 : Asia-Pacific Market Shares for Cancer Profiling and Pathway Technologies, by Country, 2024
Figure 48 : South American Market Shares for Cancer Profiling and Pathway Technologies, by Product Type, 2024
Figure 49 : South American Market Shares for Cancer Profiling and Pathway Technologies, by Profiling Type, 2024
Figure 50 : South American Market Shares for Cancer Profiling and Pathway Technologies, by Technology Type, 2024
Figure 51 : South American Market Shares for Cancer Profiling and Pathway Technologies, by Application, 2024
Figure 52 : South American Market Shares for Cancer Profiling and Pathway Technologies, by Country, 2024
Figure 53 : MEA Market Shares for Cancer Profiling and Pathway Technologies, by Product Type, 2024
Figure 54 : MEA Market Shares for Cancer Profiling and Pathway Technologies, by Profiling Type, 2024
Figure 55 : MEA Market Shares for Cancer Profiling and Pathway Technologies, by Technology Type, 2024
Figure 56 : MEA Market Shares for Cancer Profiling and Pathway Technologies, by Application, 2024
Figure 57 : MEA Market Shares for Cancer Profiling and Pathway Technologies, by Sub-region, 2024
Figure 58 : Global Market Shares for Cancer Profiling and Pathway Technologies, by Company, 2024
Figure 59 : Advantages of ESG for Companies
Figure 60 : 10X Genomics Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 61 : 10X Genomics Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 62 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 63 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 64 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 65 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 66 : Exact Sciences Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 67 : Exact Sciences Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 68 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2024
Figure 69 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2024
Figure 70 : Grail Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 71 : Grail Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 72 : Guardant Health Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 73 : Guardant Health Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 74 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 75 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 76 : Qiagen: Revenue Shares, by Business Unit, FY 2024
Figure 77 : Qiagen: Revenue Shares, by Country/Region, FY 2024
Figure 78 : Sysmex Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 79 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 80 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024